Bibliography
Found 1068 results
Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol. 2015 ;21(1):56-65.
. Global protein sequence variation in HIV-1B isolates derived from human blood and brain in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.
. . HIV-1 in the CNS: Serotonergic Deficits and Depression. In: International Society for NeuroVirology. International Society for NeuroVirology. San Diego, CA; 2015.
. HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 ;212(10):1563-73.
. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci. 2015 ;35(5):1921-38.
HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase. J Biol Chem. 2015 ;290(52):30931-46.
HIV-infected microglia mediate cathepsin B-induced neurotoxicity. J Neurovirol. 2015 ;21(5):544-58.
. Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. Am J Pathol. 2015 ;185(8):2246-58.
. Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme. Br J Pharmacol. 2015 ;172(19):4603-14.
. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. J Neuroinflammation. 2015 ;12:72.
. Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. AIDS. 2015 ;29(16):2081-92.
. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25420915
. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 ;74(8):791-803.
. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res. 2015 ;13(1):43-54.
. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. Clin Infect Dis. 2015 ;61(9):1476-84.
Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. Journal of NeuroVirology. Journal of Neurovirology. 2015 .
. The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies. Database (Oxford). 2015 ;2015:bav074.
. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 ;60(3):473-80.
Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection. AIDS Behav. 2015 ;19(1):166-77.
. Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C. Neurol Neuroimmunol Neuroinflamm. 2015 ;2(1):e59.
Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder. Mol Cell Biol. 2015 ;35(21):3684-700.
Optimizing measures of HIV-associated neuropathy. Muscle Nerve. 2015 ;51(1):56-64.
. A pathological perspective on the natural history of cerebral atherosclerosis. Int J Stroke. 2015 ;10(7):1074-80.
.